What is Cytotron therapy?

 

Cytotron therapy is a clinically proven, non-invasive treatment to arrest tumor cell growth and provide improved quality of life to cancer patients.

 

How is Cytotron (RFQMR) therapy done?

 

Patient lies on the Cytotron bed that moves into the focus area. The treating rays are focused on the tumour with laser guides and the computer calculates the dose based on the MRI, The treatment is usually one hour daily for 28 days.

 

How does Cytotron work?

 

Cytotron device produces Rotational Field Quantum Magnetic Resonance (RFQMR) beams that are low power, non-ionizing, non thermal, radio or sub-radio frequency electromagnetic waves. RFQMR alters Cell Membrane Potential of cancerous cells from problematic -20 mV to healthy -90 mV range and activates P53 proteins that halt uncontrolled cell mitosis. RFQMR does not destroy the cancer cells, but stops the cell division putting the cells in a vegetative state and as all cells are programmed by nature for self destruction through apoptosis the body gets rid of cancerous cells over time.

 

How effective is RFQMR for Cancer?

 

Preliminary study on terminal cancer patients reported that tumor progression stopped or reversed in most patients - 80% had pain relief, 60% survived beyond expectation and 35 % were alive and disease free after 2 years and many even went back to normal activity. We consider this as an outstanding result as all these patients were declared terminal cancer patients and not expected to live long. In early stages better result are expected.

 

What are the possible future uses of Cytotron?

 

Cytotron has potential in treating Cancer, Osteoarthritis, Coronary Angiogenesis, Peripheral Artery Disease, Pain management, Osteoporosis, Migraine, Diabetes, Neuropathy, Non-healing wounds, Tinnitus, Multiple Sclerosis and cerebral degeneration, etc.

 

How does the patient know that he is better?

 

Patients are expected to have better quality of life, feel better, have pain relief, eat better and feel more energetic. Pre and post Cytotron MRI can document the tumor to become static and stop growing. Follow up MRIs should show decrease of tumor mass.

 

What is the present status of Cytotron therapy?

 

Cytotron has international patent manufactured in compliance with ISO 9001:2000 and ISO 13485:2003. It has obtained CE Certificate marking European Conformity for safety, public health and consumer protection and has qualified for CMDCAS, Canada's Health regulatory requirements making it acceptable in Europe and Canada for tissue regeneration and degeneration.